Ariez B.V.

Prof. Dean Fennell and Prof. Gareth Griffiths

Ariez Publishing

Professors Dean Fennell and Garteh Griffiths, co-lead investigators of the phase III CONFIRM trial, share the results of the study of nivolumab and discuss what these results mean for patients with relapsed mesothelioma.